MVP 1.27% 40.0¢ medical developments international limited

Ann: 2024 Half Year Announcement, page-26

  1. 1,405 Posts.
    lightbulb Created with Sketch. 561
    They are lifting prices in an environment where procurement teams will be tasked with savings. Procurement teams dont / wont give a rats about the downstream savings vs competitor products so you are left to sell in at very very senior levels and ensure the customer is collaborative and skilled enough to measure the financial benefit of adopting the whistle.
    The disadvantage at unit cost is something MacGregor is choosing to ignore or even worse risk decreases in distribution due to price rises.
    He has skills but reading the room in terms of what is needed to increase penetration is not one of them and the board seem lackluster in this space too.
    Following on Linkedin looks at thought hey have let a few people go. Spending on consultants is also a great way to dispose of funds easily with nothing to show for it, I wonder if they learnt this lesson....
    Quite frustrated they lack some basic direction and foresight I considered they should have.
 
watchlist Created with Sketch. Add MVP (ASX) to my watchlist
(20min delay)
Last
40.0¢
Change
0.005(1.27%)
Mkt cap ! $34.09M
Open High Low Value Volume
40.0¢ 40.0¢ 39.5¢ $26.06K 65.43K

Buyers (Bids)

No. Vol. Price($)
2 14833 40.0¢
 

Sellers (Offers)

Price($) Vol. No.
40.5¢ 14971 4
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
MVP (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.